Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. 1979

K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer

Pinane-thromboxane A2 (PTA2, [1alpha,2 beta(Z),-3 alpha (1E,3R*),5 alpha]-7-(3-(3-hydroxy-1-octenyl)-6,6-dimethylbicyclo[3.1.1]hept-2-yl)-5-heptenoic acid) has been synthesized and tested for biological activity in systems responsive to thromboxane A2, stable prostaglandin endoperoxide (PGH2) analogs, and prostatacyclin (PGI2). At low concentrations, PTA2 inhibited cat coronary artery constriction induced by stable prostaglandin endoperoxide analogs, and it stabilized liver lysosomes. At slightly higher concentrations, it inhibited platelet aggregation. At still higher concentrations, PTA2 inhibited thromboxane synthetase, but it had no effect on prostacyclin synthetase. The analog also had no effect on the inhibition of platelet aggregation by PGI2 or prostaglandin D2. It is suggested that PTA2 has a suitable biochemical profile for use as an antithrombotic agent.

UI MeSH Term Description Entries
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081008 Bicyclic Monoterpenes Monoterpenes containing two ring structures that are joined either by bridgehead carbon atoms or fused ring structure. Camphene Derivatives,Camphenes,Carane Derivatives,Caranes,Pinane Derivatives,Pinanes,Thujane Derivatives,Thujanes,Derivatives, Camphene,Derivatives, Carane,Derivatives, Pinane,Derivatives, Thujane,Monoterpenes, Bicyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001158 Arteries The vessels carrying blood away from the heart. Artery
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
November 1982, Prostaglandins, leukotrienes, and medicine,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
January 2001, Zeitschrift fur Naturforschung. C, Journal of biosciences,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
January 1978, Pharmacological research communications,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
January 1985, Nature,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
August 1998, Journal of cardiovascular pharmacology,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
March 1989, FEBS letters,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
July 1991, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
June 1997, The Journal of pharmacology and experimental therapeutics,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
January 1980, Advances in prostaglandin and thromboxane research,
K C Nicolaou, and R L Magolda, and J B Smith, and D Aharony, and E F Smith, and A M Lefer
January 1987, Haemostasis,
Copied contents to your clipboard!